信铭生命科技(00474):14.76亿股代价股份经已配发及发行予IFGL的代名人

智通财经
Mar 03

智通财经APP讯,信铭生命科技(00474)发布公告,认购协议所载的所有条件已于2026年3月3日获达成,而完成已于2026年3月3日根据认购协议的条款及条件作实。

完成后,IFGL将不会成为本公司的附属公司,而将作为本公司以公平值计量且其变化计入其他全面收益的金融资产入账。

完成后,14.76亿股代价股份经已配发及发行予IFGL的代名人。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10